Skip to the main content.
Login Contact us
shine-bright-diamond-neuro-1
Neuroainewlogo-1

by Arterys®

 

AI gets real.
Your All-in-One Neuroradiology Platform.


The Neuro AI platform is a vendor neutral comprehensive suite of clinically useful AI neuroimaging applications that provide physicians with fully automated, and easy-to-interpret customizable reporting -- facilitating fast and accurate diagnostic and treatment decisions for stroke, neurodegenerative disease, multiple sclerosis and brain tumor patients.

ONcology (6)

 

Fast Decisions

 

Make faster and more data-driven treatment decisions – reducing delays in identifying and acting on patients with abnormal brain medical images when time is critical

Consistent Results

 

Access standardized results – minimizing variability associated with subjective interpretation

More Productivity

 

Reduce tedious manual tasks and increasing productivity with access to automated and quantitative brain imaging analysis and customizable reporting

Optimized Workflow

 

Anytime anywhere access to results through a single user interface zero-footprint viewer and an internet connection - No on-premises hardware required.

Ease of Integration

 

One integration and user interface to gain access to all AI and images with no app switching cost

Neurodegenerative Disease

 

The Neuro AI platform solution for neurodegenerative disease uses AI-based segmentation that provides an accurate and consistent quantitative evaluation of T1-weighted MRI brain scan. The solution offers an automated report that allows users to view a comparison over time, enabling measurements that were impossible to obtain within the time constraints of the clinical workflow using a manual approach.

AI-powered by Combinostics

Combinostics Logo Transparant background

Neuro Degenerative
 

Multiple Sclerosis

 

The Neuro AI platform solution for multiple sclerosis is an automated, reproducible, and accurate tool to detect and quantify white matter lesions on FLAIR MR images. Therefore it delivers an efficient, objective disease activity assessment and determines the best course of treatment. The solution provides data-driven lesion tracking and standardizes reporting for a more efficient workflow and improved communication for both clinicians and patients

AI-powered by Combinostics

Combinostics Logo Transparant background

MS Dementia (1)
 

Stroke Suite

 

Time is brain when it comes to detecting stroke. Using deep learning technologies with robust validation processes to match real-life expectations, the Neuro AI platform’s Stroke Suite detects and prioritizes acute LVO and ICH cases, analyzes CT and MR perfusion, and notifies the radiologist and the care team within their existing systems and workflow.

AI powered by Avicenna and Cercare Medical

Avicenna and Cercare-1

 

Stroke (9)
 

Cerebral 4D Flow


The Neuro AI platform’s Cerebral 4D Flow is the only solution on the market that leverages Arterys’ 4D flow post-processing technology to visualize and quantify flow measurements in the carotids and intracranial vessels. Cerebral 4D Flow is the only available solution that demonstrates early hemodynamic changes in arteriovenous malformation and monitors blood flow in aneurysms and stenosis. It also provides tools to assess the blood flow of pediatric patients and enables physicians to better plan interventions and stents.

4D Flow (14)
 

Neuro-Oncology Suite

 

The Neuro-Oncology Suite is part of the Neuro AI platform and it provides tools to non-invasively diagnose and follow up on brain tumors. This solution offers a robust algorithm to distinguish tumors from pseudo-progression with >95% accuracy.

AI powered by Imaging Biometrics

ImagingBiometrics

 

ONcology (2)
 

Learn more about Neuro AI

Speak with an Arterys expert about how Neuro AI can help your team achieve fast, consistent results within your current workflow.

Schedule a Demo

More Neuroradiology information from the Arterys Blog

ASNR 2022 Highlighted Critical Challenges and the Latest Tech Solutions

Neuroradiologists and other radiology subspecialties face unprecedented challenges, with this month's ASNR annual event...

New All-in-One Neuroradiology Platform To Be Showcased at ASNR 2022

Next month, the Annual Meeting of the American Society of Neuroradiology will be held in tandem with the Symposium...

A New Solution for Assessing Patients with Multiple Sclerosis and Dementia

We have exciting news to share! The Arterys all-in-one neuroradiology Neuro AI platform has launched a new automated...

Arterys has joined Tempus, and we are excited to reintroduce ourselves to you as Tempus Radiology.
Tempus is a leading technology company that is advancing precision medicine through the practical application of data and artificial intelligence in healthcare. By joining forces, Arterys’ product will be integrated into Tempus’ solutions, enabling providers to access a comprehensive patient view (now inclusive of radiology scans) and researchers to leverage this new data modality to optimize the drug development process.